Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

Reuters NewMedia - Friday December 14, 2001
Steven Swindells

Pretoria High Court Judge Chris Botha ruled that the government was obliged to provide the AIDS drug nevirapine to pregnant women.

The government is expected to appeal the 70-page ruling before the country's Supreme Court.

The AIDS activist group Treatment Action Campaign (TAC), backed by doctors, had launched the court action, arguing the government had a duty to offer nevirapine under the constitutional right to health treatment.

"This is a very important victory, a great step forward. The judge granted everything that the TAC sought, he ordered that nevirapine be made available at health facilities across the country," TAC national secretary Mark Heywood told Reuters.

No health ministry officials were available for immediate comment on the ruling and no government officials were present at the court.

Under the ruling, the health department has to return to court by March 31 to show how it will roll out the national nevirapine program.

The government has refused to implement such a scheme at public hospitals and clinics, citing cost and safety concerns surrounding the drug. Between 70,000 and 100,000 babies are born HIV-positive yearly in South Africa, which has more people living with HIV/AIDS than any other country in the world, with one in nine of its people estimated to be HIV-positive.

A dose of nevirapine--a tablet given to the mother during labor and a teaspoon of syrup to the baby within the first 72 hours of birth--can cut mother-to-child infection rates by up to 50%.

The government's approach to the epidemic has been mired in controversy since President Thabo Mbeki questioned the causal link between HIV and AIDS and said life-prolonging retrovirals were as toxic as the condition they were meant to treat.

Germany's Boehringer Ingelheim, which makes nevirapine, has offered the drug free to the government for five years.

"The offer is still there. If the government decides to move forward we would be happy to supply the product," Kevin McKenna, Boehringer Ingelheim's managing director in South Africa, said.

The South African government won a landmark case against 39 of the world's biggest drug firms this year that opened the way for Pretoria to import cheaper versions of AIDS drugs, including antiretrovirals. But Pretoria has not reached an agreement with drug manufacturers or suppliers to get cheaper drugs.
011214
RE011225

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .